Close

Guidance for Emergent BioSolutions, Inc. (EBS)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2023 N/A N/A $1.00B – 1.10B $1.04B = Maintained Details
2023 N/A N/A $1.15B $1.18B = Maintained Details
2021 N/A N/A $1.95B – 2.05B $1.93B = Maintained Details
Q3 2021 N/A N/A $1700.00B – 1900.00B $1.80B = Maintained Details
Q2 2021 N/A N/A $370.00M – 430.00M $502.30M Lowered Details
2020 N/A N/A $1.50B – 1.60B $1.39B Raised Details
Q3 2020 N/A N/A $420.00M – 450.00M $420.20M Raised Details
2019 N/A N/A $1.06B – 1.14B $1.08B = Maintained Details
Q2 2019 N/A N/A $200.00M – 220.00M $254.14M = Maintained Details
2018 N/A N/A $715.00M – 755.00M $706.00M = Maintained Details
2018 $770.00 – $800.00 $741.00 N/A N/A = Maintained Details
2018 N/A N/A $715.00M – 755.00M $738.54M = Maintained Details
Q2 2018 N/A N/A N/A N/A = Maintained Details
Q4 2017 N/A N/A N/A N/A = Maintained Details
Q3 2017 N/A N/A N/A N/A = Maintained Details
Q2 2017 N/A N/A N/A N/A = Maintained Details
Q1 2017 N/A N/A N/A N/A = Maintained Details
2015 N/A N/A $510.00M – 540.00M N/A = Maintained Details
2014 N/A N/A $440.00M – 460.00M $443.14M Raised Details
2014 N/A N/A $45.00M – 55.00M $46.80M = Maintained Details
2013 N/A N/A $290.00M – 310.00M $314.71M = Maintained Details
2013 N/A N/A $40.00M – 50.00M $60.00M Lowered Details
2013 N/A N/A $290.00M – 310.00M $300.60M = Maintained Details
2012 N/A N/A $280.00M – 300.00M $304.50M = Maintained Details
2012 N/A N/A $60.00M – 70.00M $78.32M = Maintained Details
2012 N/A N/A $280.00M – 300.00M $292.99M = Maintained Details
Q2 2012 N/A N/A $70.00M – 80.00M $76.60M = Maintained Details
2011 N/A N/A $270.00M – 290.00M $326.68M = Maintained Details